Roquette, the pea protein specialist, has inked an agreement with Israeli seed breeding tech company Equinom to develop and source new high-protein pea varieties.
Additionally, Fortissimo Capital, the company’s current shareholder, is investing $4 million to further development.
Roquette said that the agreement positions it on the cutting-edge of new non-GMO plant variety development which, it says, addressed industrial needs and consumer expectations.
“This investment represents a great partnership and a major step forward in the implementation of the Group’s strategy in plant-based proteins,” said Pascal Leroy, Vice-President of Roquette’s Pea and New Protein business line.
“By contributing to develop new responsible and sustainable high-protein pea production thanks to this collaboration, we are demonstrating our goal of offering products increasingly tailored to the needs of food, nutrition and health markets, and to better answer a growing customer and consumer demand.”
Gil Shalev, Equinom founder and CEO, added: “The agreement with Roquette is a major milestone for Equinom, and its investment in our company is a vote of confidence in our technology and its ability to transform the plant-protein market.
“The agreement will guarantee the full commercialisation of Equinom’s high-protein pea varieties. It will also facilitate the introduction of additional plant protein to market and enable Equinom to attain its mission of increasing the production of high-quality, sustainable food ingredients that are changing the types of foods consumed.”